Identifying Factors Underlying the Discontinuation of Triptans

Mayo Clinic

Status: Completed

Conditions: Medication Adherence; Migraine

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00890357

09-0111

Details and patient eligibility

About

The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.

Enrollment: 292 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Triptan User Inclusion Criteria:

• Episodic Migraine or Chronic Migraine
• Have used a triptan medication in the prior 3 months
• Have used triptan medications for at least 1 year

Triptan Discontinuation Inclusion Criteria:

• Episodic Migraine or Chronic Migraine
• Used any triptan medication in the last 2 years
• Have not used a triptan medication in the last 6 months

Trial design

292 participants in 2 patient groups

Triptan User

Triptan Discontinued